Phase shift colloids as ultrasound contrast agents

Details Phase shift colloids as ultrasound contrast agents Phase shift colloids as ultrasound contrast agents

A - Human Necessities

61

K

A61K 49/00 (2006.01) A61K 49/22 (2006.01)

Patent

CA 2154590

Agents for enhancing the contrast in a diagnostic ultrasound procedure comprise colloidal dispersions of the liquid-in-liquid type, i.e., emulsions or microemulsions, in which the dispersed liquid phase is a liquid having a boiling point below the temperature of the animal to be imaged and which undergoes a phase change from a dispersed liquid to a highly echogenic dispersed gaseous foam or kugelschaum following administration to the animal. The liquid state of the dispersed phase allows one to manufacture extremely stable, pharmaceutically acceptable emulsions with particle sizes typically below 1000 nm. The gaseous state at body temperature yields highly echogenic microbubbles, typically below 10,000 nm in diameter, which are effective as ultrasound contrast agents. Intravenous, intraarterial, oral, intraperitoneal, and intrauterine dosage forms, methods of administration, and imaging techniques are described.

Affiliated with

Also associated with

Rating

Phase shift colloids as ultrasound contrast agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Phase shift colloids as ultrasound contrast agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phase shift colloids as ultrasound contrast agents will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2020588